Filter Results :

Your search for Diabetes returned 138 reports

Sort by


Diabetes Care Devices Market Global Report 2017

17 Jul 2017  |  Published by:  Business Research Company
Diabetes Care Devices Market Global Report 2017Including: Blood Glucose Test Strips, Insulin Pens, Insulin Syringes, Insulin Pumps And Injectors, Lancing Devices, Continuous Glucose Monitoring Devices , Blood Glucose MetersCovering: Roche, J&J, Medtronic, Abbott, and BectonThe diabetes care devi...

$ 6,000.00

Read More

Abbott Diabetes Care Inc - Medical Equipment - Deals and Alliances Profile

11 Jul 2017  |  Published by:  GlobalData
SummaryAbbott Diabetes Care Inc (ADC), formerly TheraSense Inc, a subsidiary of Abbott Laboratories, is a medical device company that discovers, develops, manufactures, and markets pharmaceuticals and medical products for personal use and hospital use. The company's products include glucose monitori...

$ 250.00

Read More

Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 - 2022

01 Jul 2017  |  Published by:  DPI Research
Diabetes Reusable Insulin Pen Market is likely to reach more than US$ 3 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022.Market growth can be attributed to factors such as growing d...

$ 1,100.00

Read More

Global Diabetes Disposable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 - 2022

01 Jul 2017  |  Published by:  DPI Research
Diabetes Disposable Insulin Pen Market is likely to reach more than US$ 9 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022.Market growth can be attributed to factors such as growing...

$ 1,100.00

Read More

Global Next Generation Diabetes Therapy Market Research Report 2017

22 Jun 2017  |  Published by:  9Dimen Research
Next Generation Diabetes Therapy Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (Unit...

$ 2,850.00

Read More

Type 1 Diabetes (Juvenile Diabetes)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Type 1 Diabetes (Juvenile Diabetes)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Type 1 Diabetes (Juvenile Di...

$ 2,000.00

Read More

Diabetes Insipidus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Diabetes Insipidus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Diabetes Insipidus Report is to understand th...

$ 2,000.00

Read More

Type 1 Diabetes (Juvenile Diabetes)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jun 2017  |  Published by:  DelveInsight
Summary'Type 1 Diabetes (Juvenile Diabetes)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understan...

$ 2,000.00

Read More

Diabetes Insipidus Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jun 2017  |  Published by:  DelveInsight
Summary'Diabetes Insipidus- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manu...

$ 2,000.00

Read More

Type 1 Diabetes (Juvenile Diabetes)-API Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API ...

$ 1,250.00

Read More

Type 2 Diabetes - Pipeline Review, H1 2017

30 May 2017  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Pipeline Review, H1 2017, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.Type 2 diabetes is a chronic condition and is the most common form of diabetes. ...

$ 2,500.00

Read More

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2017

30 May 2017  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2017, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline landscape.Type 1 diabetes (T1D) is an autoimmune d...

$ 2,500.00

Read More

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H1 2017

30 May 2017  |  Published by:  Global Markets Direct
SummaryAccording to the recently published report 'Islet Amyloid Polypeptide - Pipeline Review, H1 2017'; Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) pipeline Target constitutes close to 14 molecules. Out of which approximately 12 molecules...

$ 3,500.00

Read More

Thermalin Diabetes LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

17 May 2017  |  Published by:  GlobalData
SummaryThermalin Diabetes LLC (Thermalin) is an insulin analogs developer. The company develops concentrated insulin analog for the treatment of individuals with insulin resistance and for use in miniature insulin pumps. It develops both molecular and formulation strategies to produce an acting anal...

$ 250.00

Read More

IVD Market in BRIC by Product & Service (Instruments, Reagents, Software), Technology (Immunoassay, Hematology, Microbiology), Application (Diabetes, Cardiology, Infectious Diseases), Country (Brazil, Russia, India, China) - Forecast to 2022

08 May 2017  |  Published by:  MarketsandMarkets
The IVD market in BRIC is expected to reach USD 15.71 billion by 2022 from USD 10.60 billion in 2017, at a CAGR of 8.2%. The key factors driving the growth of the market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the num...

$ 5,650.00

Read More
Total 138 records.